Inside Indonesia's Harsh Cannabis Mandatory Minimums

October 4, 2026

Photo by Arif Syuhada via Pexels.

Grow five cannabis plants in your backyard in Jakarta, get caught, and you are not looking at a fine or a diversion program. Under Indonesian law you are looking, in the worst case, at a firing squad. That is not rhetorical flourish -- it is the literal sentencing band written into the statute. Indonesia's drug law does not treat quantity as a sliding scale of concern; it treats certain thresholds as triggers for the harshest penalty the state has.

The backbone of this system is Law No. 35 of 2009 on Narcotics, known locally as Undang-Undang Narkotika. It is a law built on mandatory minimums rather than judicial discretion -- meaning that once prosecutors establish a quantity or a charge category, the sentencing range is largely locked in before a judge ever weighs intent, circumstance, or harm. Fifteen years on, that rigidity is colliding with a domestic reform push led by families of chronically ill patients, legal aid lawyers, and a handful of sympathetic physicians, all pressing for some kind of medical carve-out. The law hasn't moved. The pressure on it has only grown.

The Legal Architecture: Law No. 35 of 2009

Photo by Firman Marek_Brew via Pexels.

Law No. 35 of 2009 tentang Narkotika sorts every controlled substance into one of several Golongan, or groups, based on purported danger and medical value. Cannabis sits in Golongan I, the top tier, alongside heroin and methamphetamine -- substances the law treats as having no recognized medical use and the highest potential for abuse. That classification is the single most consequential fact in Indonesian cannabis policy, because it determines which sentencing article applies before any judge ever considers the specifics of a case.

Article 127 covers personal use and is the one meaningful pressure valve in the entire statute: up to four years imprisonment and/or mandatory rehabilitation. It's the only place where a judge has real room to route someone toward treatment instead of prison, and even that discretion is narrower than it sounds, as later sections make clear.

Move one step up -- possession, cultivation, or supply without the aggravating quantity triggers -- and the law shifts to a 4-to-12-year range, paired with fines running from Rp 800 million up to Rp 8 billion (roughly $50,000 to $500,000 USD at typical exchange rates). These are not caps a judge can waive down to zero; they're floors as much as ceilings.

Then there's the aggravated tier, which is where Indonesia's law becomes genuinely unusual by regional standards. Cross a threshold of more than 1 kilogram or 5 plants of Group I plant material, or more than 5 grams of processed Group I material, and the available sentences jump to death, life imprisonment, or 5-to-20 years plus category V-VI fines, which run into the billions of rupiah. The architecture here is the key point: these bands are mandatory minimums baked directly into the statute, not discretionary maximums a judge can choose to apply or not. That's what strips flexibility out of borderline cases and makes charging decisions, made long before trial, the real determinant of someone's fate.

How the Thresholds Compare: Sentencing Bands by Offense

Indonesia's cannabis sentencing escalates sharply with offense severity, from a 4-year maximum for personal use to 20 years for aggravated quantity cases, highlighting the steep penalties facing drug offenders beyond simple possession.

Lay the three tiers side by side and the jump between them is startling given how little separates the underlying conduct. Personal use under Article 127 tops out at four years, with rehabilitation as a real alternative on paper. Step into possession, cultivation, or supply territory -- even without any aggravating quantity -- and the floor alone is four years, stretching to twelve, with fines that can reach roughly half a million dollars.

The real cliff edge is the aggravated category. Once the quantity crosses 1 kilogram or 5 plants of raw plant material, or 5 grams of processed material, the sentencing range includes death and life imprisonment as live options, alongside a 5-to-20-year band and category V-VI fines. There is no intermediate step between ordinary trafficking and the most severe penalties available under Indonesian law -- the statute simply doesn't build one in.

What makes this worth visualizing rather than just listing is how little physical cannabis separates a 4-year exposure from a death-penalty exposure. Five plants is not an industrial grow operation. It's closer to what a home cultivator growing for personal medical or recreational use might have going at once, especially if a crop is still maturing and hasn't been harvested down to a smaller dried weight. A defendant whose actual intent was personal use can find themselves charged under the aggravated provision simply because the live plant count or wet weight at the time of seizure crossed the line, before any drying or processing reduced it to something resembling a typical personal stash. The thresholds were clearly drafted with trafficking organizations in mind, but they don't distinguish well between a trafficker and someone growing in a spare room.

Who Gets Caught in the Gap

Photo by sergeitokmakov via Pixabay.

The cases that get national attention in Indonesia are rarely drug kingpins. They tend to be parents -- mothers, mostly -- caught trying to source cannabis oil or raw material to manage a child's cerebral palsy, intractable epilepsy, or similar condition for which conventional treatment in Indonesia's healthcare system has limited options. These stories generate real public sympathy, even in a country where anti-narcotics messaging runs deep and the official line treats cannabis as categorically no different from methamphetamine. Sympathy, though, hasn't yet translated into legal exceptions. The statute makes no distinction for medical necessity, so a mother caught with cannabis oil for her child is formally exposed to the same possession or supply charges as anyone else.

Article 127's rehabilitation option exists, but advocates and defense lawyers describe its application as inconsistent at best. Whether someone charged with simple possession actually gets routed to rehabilitation rather than prosecuted as a dealer often comes down to decisions made well before a judge is involved.

That's because prosecutors and police hold substantial charging discretion over the threshold question that matters most: is this person a user or a supplier? The quantity found, the presence of items like scales or packaging, prior record, and plain investigative judgment all feed into that call -- and that call is what separates a four-year exposure from a twelve-year one, long before any judicial weighing of circumstance happens. Indonesia's legal aid organizations have flagged this charging-stage discretion as the point where the system's fairness actually gets decided, far more than at sentencing.

Compounding this, the 1-kilogram, 5-plant, and 5-gram thresholds sit low enough that small-scale home growers -- the exact population most likely to be patients or caregivers rather than traffickers -- can get swept into the aggravated category meant for organized supply chains. The law's text doesn't ask about intent at that stage; it asks about weight and plant count.

The Reform Movement Pushing Back

Photo by Teemu Paananen via Unsplash.

Indonesia does have a domestic reform coalition, and it's grown more organized in recent years. It's made up largely of patients' families, legal aid groups, and a small but vocal group of physicians willing to put their names behind calls for a medical cannabis exception separate from the criminal Golongan I framework that currently governs the plant. Their ask is narrow and deliberate: carve medical cannabis out of the top drug tier, rather than touch the broader criminal architecture.

That narrowness is strategic. Indonesia's Constitutional Court (Mahkamah Konstitusi) has heard petitions challenging the blanket ban as applied to cases of medical necessity, and the fact that the court has entertained these petitions at all signals some institutional awareness that the law's total rigidity creates hard cases it wasn't designed to handle. The court hasn't struck down the Golongan I classification, but its willingness to hear these challenges keeps the door open for an incremental, judicially-driven fix rather than a legislative one.

Regional context adds pressure that's hard for Jakarta to wave away entirely. Thailand decriminalized cannabis in 2022 -- a dramatic regional shift, even accounting for the policy reversals and tightening that followed. Malaysia has moved toward abolishing mandatory death sentences for drug offenses in recent years, and the Philippines, despite its own brutal drug-war history, has seen renewed debate over sentencing proportionality. Indonesia increasingly stands out as having one of the region's strictest frameworks still fully intact, and that comparison gets made in domestic reform arguments explicitly.

It's worth being precise about what reform advocates are actually asking for, because it's not broad legalization. Most proposals stop at medical access and restoring some judicial discretion in low-level personal-use cases -- not decriminalizing cultivation or supply, and certainly not opening a recreational market. Even that modest ask hasn't moved the government. Officials have consistently held the line, pointing to Indonesia's constitutional anti-narcotics posture and framing the entire drug law as a public health measure rather than purely punitive -- a framing reform advocates dispute but haven't yet dislodged.

Enforcement on the Ground

Photo by lovingimages via Pixabay.

Enforcement in Indonesia isn't abstract or occasional -- the National Narcotics Agency, Badan Narkotika Nasional (BNN), runs sustained operations year-round, including raids on cultivation sites concentrated in regions historically associated with cannabis growing, most notably Aceh. Aceh's relationship with the plant predates Indonesian statehood by centuries: cannabis has a documented pre-colonial history there as both a cooking ingredient, worked into dishes like certain meat curries, and a component of traditional medicine. That history doesn't exempt Aceh from Law No. 35 of 2009 -- Golongan I classification applies nationally -- but it does create a specific enforcement tension in a province where the plant has deeper cultural roots than almost anywhere else in the country, and where eradication operations land on communities with a longer memory of the plant as something other than a narcotic.

Foreign nationals get no separate framework. Indonesia has prosecuted and sentenced non-citizens to lengthy prison terms and, in trafficking-level cases, death, under the same aggravated thresholds that apply to Indonesian citizens. The country's drug laws have made international news before specifically because foreign defendants faced capital sentences for quantities that, elsewhere in the region, would draw far shorter terms or civil penalties.

There are release valves, but they run through executive rather than judicial channels. Grasi (clemency) and remisi (sentence reductions) exist and are granted periodically, including around national holidays, but they sit at the discretion of the president or relevant ministries -- not something a convicted person or their lawyers can claim as a matter of right. For someone serving a 15-year sentence under the aggravated provisions, grasi or remisi is a hope to petition for, not a guaranteed off-ramp, and the discretionary nature of both means outcomes vary case by case in ways that are hard to predict or systematize.

There's little reason to expect Indonesia's framework to soften on any fast timeline. The political capital invested in a tough anti-narcotics stance runs deep and spans administrations -- it's treated as a near-constitutional commitment rather than an ordinary policy position, and no major political party has put decriminalization, or even a Article 127 overhaul, on its platform. That's not a climate where legislators go looking to rewrite Law No. 35 from scratch.

The more plausible path forward is narrower and slower: medical exceptions carved out through a Constitutional Court ruling or a targeted regulatory fix, rather than a full legislative rewrite of the underlying statute. That mirrors exactly what the current reform coalition is asking for, which suggests they've read the political terrain correctly even if it means a much smaller win than full legalization advocates elsewhere in the region have secured.

If there's a place to watch for an actual shift, it's the intersection of two pressure points -- Aceh, where cultivation history and cultural practice sit uneasily against a uniform national ban, and the Constitutional Court, which has already shown a pattern of hearing narcotics-related petitions rather than dismissing them outright. Neither guarantees change. But both are the kind of friction points where rigid statutes eventually get forced to bend, even in a country that has shown no appetite for bending voluntarily.